| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9097686 | Journal of Critical Care | 2005 | 7 Pages |
Abstract
When administered in prophylactic doses to critically ill patients with a wide range of calculated creatinine clearances, we found no evidence of bioaccumulation of dalteparin. If dalteparin does not bioaccumulate, it may be an attractive alternative agent for thromboprophylaxis.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Christian G. (MSc(Epi)), Deborah J. (MSc(Epi)), Mark A. (MSc(Epi)), Ellen RN, France RRT, M.O. (MSc(Epi)), Ker-Ai MMath, Richard J. PhD,